NASDAQ: RLAY · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Relay Therapeutics Inc.

How Relay Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$4.3B

Price

$19.47

P/E

-14.9

EPS (TTM)

$-1.31

1-year return

166.3%

Dividend yield

0.0%

52-week range

$6.38–$19.47

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources